1481 related articles for article (PubMed ID: 20633378)
1. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
George MS; Ward HE; Ninan PT; Pollack M; Nahas Z; Anderson B; Kose S; Howland RH; Goodman WK; Ballenger JC
Brain Stimul; 2008 Apr; 1(2):112-21. PubMed ID: 20633378
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
[TBL] [Abstract][Full Text] [Related]
3. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders.
Jiménez F; Nicolini H; Lozano AM; Piedimonte F; Salín R; Velasco F
World Neurosurg; 2013; 80(3-4):S30.e17-25. PubMed ID: 22824558
[TBL] [Abstract][Full Text] [Related]
4. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
5. Combined bilateral anterior cingulotomy and ventral capsule/ventral striatum deep brain stimulation for refractory obsessive-compulsive disorder with major depression: do combined procedures have a long-term benefit?
Chang WS; Roh D; Kim CH; Chang JW
Restor Neurol Neurosci; 2013; 31(6):723-32. PubMed ID: 23979095
[TBL] [Abstract][Full Text] [Related]
6. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.
Nahas Z; Marangell LB; Husain MM; Rush AJ; Sackeim HA; Lisanby SH; Martinez JM; George MS
J Clin Psychiatry; 2005 Sep; 66(9):1097-104. PubMed ID: 16187765
[TBL] [Abstract][Full Text] [Related]
7. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.
Aaronson ST; Carpenter LL; Conway CR; Reimherr FW; Lisanby SH; Schwartz TL; Moreno FA; Dunner DL; Lesem MD; Thompson PM; Husain M; Vine CJ; Banov MD; Bernstein LP; Lehman RB; Brannon GE; Keepers GA; O'Reardon JP; Rudolph RL; Bunker M
Brain Stimul; 2013 Jul; 6(4):631-40. PubMed ID: 23122916
[TBL] [Abstract][Full Text] [Related]
8. Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder.
Mantione M; Nieman DH; Figee M; Denys D
Psychol Med; 2014 Dec; 44(16):3515-22. PubMed ID: 25065708
[TBL] [Abstract][Full Text] [Related]
9. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.
Sackeim HA; Rush AJ; George MS; Marangell LB; Husain MM; Nahas Z; Johnson CR; Seidman S; Giller C; Haines S; Simpson RK; Goodman RR
Neuropsychopharmacology; 2001 Nov; 25(5):713-28. PubMed ID: 11682255
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
Cristancho P; Cristancho MA; Baltuch GH; Thase ME; O'Reardon JP
J Clin Psychiatry; 2011 Oct; 72(10):1376-82. PubMed ID: 21295002
[TBL] [Abstract][Full Text] [Related]
11. Transcranial direct current stimulation in treatment-resistant obsessive-compulsive disorder: An open-label pilot study.
Bation R; Poulet E; Haesebaert F; Saoud M; Brunelin J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():153-7. PubMed ID: 26439873
[TBL] [Abstract][Full Text] [Related]
12. Maintenance treatment for obsessive-compulsive disorder: findings from a naturalistic setting.
Peselow ED; Pizano DR; IsHak WW
Ann Clin Psychiatry; 2015 Feb; 27(1):25-32. PubMed ID: 25696778
[TBL] [Abstract][Full Text] [Related]
13. Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities?
Storch EA; Lewin AB; Farrell L; Aldea MA; Reid J; Geffken GR; Murphy TK
J Anxiety Disord; 2010 Aug; 24(6):547-52. PubMed ID: 20399603
[TBL] [Abstract][Full Text] [Related]
14. Internet-Based Cognitive Behavioral Therapy With Real-Time Therapist Support via Videoconference for Patients With Obsessive-Compulsive Disorder, Panic Disorder, and Social Anxiety Disorder: Pilot Single-Arm Trial.
Matsumoto K; Sutoh C; Asano K; Seki Y; Urao Y; Yokoo M; Takanashi R; Yoshida T; Tanaka M; Noguchi R; Nagata S; Oshiro K; Numata N; Hirose M; Yoshimura K; Nagai K; Sato Y; Kishimoto T; Nakagawa A; Shimizu E
J Med Internet Res; 2018 Dec; 20(12):e12091. PubMed ID: 30559094
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ
J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179
[TBL] [Abstract][Full Text] [Related]
16. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
18. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
Coric V; Taskiran S; Pittenger C; Wasylink S; Mathalon DH; Valentine G; Saksa J; Wu YT; Gueorguieva R; Sanacora G; Malison RT; Krystal JH
Biol Psychiatry; 2005 Sep; 58(5):424-8. PubMed ID: 15993857
[TBL] [Abstract][Full Text] [Related]
19. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
Feusner JD; Kerwin L; Saxena S; Bystritsky A
Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
